When to Refer for Intravenous Iron Therapy
Refer patients for IV iron when they have insufficient response to oral iron (hemoglobin increase <1 g/dL or ferritin not reaching 30-50 ng/mL within 4-12 weeks), cannot tolerate oral iron due to gastrointestinal side effects, have malabsorptive conditions, require rapid correction of iron deficiency, or are pregnant in the second/third trimester with iron deficiency anemia. 1
Clear Indications for IV Iron Referral
Based on the most recent 2025 Lancet Haematology consensus guidelines, IV iron is indicated over oral iron in the following specific scenarios:
Primary Indications (Adults)
- Oral iron failure: After 4-12 weeks of oral iron therapy, hemoglobin has not increased by ≥1 g/dL OR ferritin has not reached 30-50 ng/mL 1
- Oral iron intolerance: Gastrointestinal side effects preventing adherence to daily oral iron 1
- Malabsorptive conditions: Celiac disease, inflammatory bowel disease, post-bariatric surgery, atrophic gastritis 1, 2
- Rapid correction needed: Severe symptomatic anemia, upcoming surgery, or clinical urgency 1
- Chronic inflammatory conditions: Chronic kidney disease, heart failure, inflammatory bowel disease, cancer-related anemia 1, 2
- Ongoing blood loss: When iron losses exceed what oral supplementation can replace 1, 2
Pregnancy-Specific Indications
- Second and third trimester: IV iron is preferred over oral iron for iron deficiency anemia to improve maternal outcomes 1
- First trimester: Oral iron remains preferred; IV iron reserved for intolerance or insufficient response 1
Pediatric Indications
- Insufficient response to oral iron: Assessed at 4 weeks for anemia or 12 weeks for non-anemic iron deficiency 1
- Inability to take oral iron or documented intolerance 1
Important Timing Considerations
Do not assess response to IV iron sooner than 4 weeks post-infusion, as iron parameters transiently increase immediately after administration and do not accurately reflect true iron stores during this period 1. This is a common pitfall that leads to premature re-dosing or misinterpretation of treatment efficacy.
What Does NOT Require IV Iron
The 2025 guidelines explicitly state there is no clear preference for IV versus oral iron as first-line therapy in treatment-naive patients without the above indications 1. Starting with oral iron (ferrous sulfate 325 mg daily or alternate-day dosing) remains appropriate for uncomplicated iron deficiency without malabsorption, intolerance, or urgent correction needs 1, 2.
Safety Profile Supporting Liberal Use
IV iron has a low risk of serious adverse events when indicated 1, with infusion reactions occurring rarely 3. Modern formulations are considerably safer than historical preparations, though formulation-dependent hypophosphatemia (particularly with ferric carboxymaltose) requires monitoring in high-risk patients 1, 3.
Practical Implementation
For patients requiring IV iron, prefer total dose infusion over multiple-dose treatment 1, and do not routinely pre-medicate unless the patient has a history of infusion reactions, multiple severe drug allergies, or inflammatory arthritis 1. Develop long-term monitoring plans for patients with ongoing risk factors for recurrent deficiency 1.